AlphaYouAC
Schedule 13G filing
ADAR1 Capital Management, LLC disclosed a 17.2% stake in InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC reported owning 17.2% of InMed Pharmaceuticals Inc. (INM) (943,668 shares) in a Schedule 13G filed Oct 7, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 7, 2026
- Source
- Schedule 13G
More INM insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.